CO2021011057A2 - Composición cosmética/dermatológica - Google Patents

Composición cosmética/dermatológica

Info

Publication number
CO2021011057A2
CO2021011057A2 CONC2021/0011057A CO2021011057A CO2021011057A2 CO 2021011057 A2 CO2021011057 A2 CO 2021011057A2 CO 2021011057 A CO2021011057 A CO 2021011057A CO 2021011057 A2 CO2021011057 A2 CO 2021011057A2
Authority
CO
Colombia
Prior art keywords
cosmetic
dermatological composition
present
composition
pharmaceutical
Prior art date
Application number
CONC2021/0011057A
Other languages
English (en)
Inventor
Denis Barritault
Original Assignee
Organes Tissus Regeneration Reparation Remplacement
Denis Barritault
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organes Tissus Regeneration Reparation Remplacement, Denis Barritault filed Critical Organes Tissus Regeneration Reparation Remplacement
Publication of CO2021011057A2 publication Critical patent/CO2021011057A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86—Polyethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/592—Mixtures of compounds complementing their respective functions
    • A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención es concerniente con una composición farmacéutica o dermatológica y con su uso como medicamento. La presente invención también es concerniente con una composición cosmética o dermatológica, también como con un kit de cuidado que incluye la composición de la invención. La presente invención encuentra aplicación en particular en los campos cosmético, farmacéutico y veterinario.
CONC2021/0011057A 2019-01-24 2021-08-23 Composición cosmética/dermatológica CO2021011057A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19305095.2A EP3685822A1 (fr) 2019-01-24 2019-01-24 Composition cosmetique/dermatologique
PCT/EP2019/087146 WO2020151900A1 (fr) 2019-01-24 2019-12-30 Composition cosmetique/dermatologique

Publications (1)

Publication Number Publication Date
CO2021011057A2 true CO2021011057A2 (es) 2021-09-20

Family

ID=65409021

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2021/0011057A CO2021011057A2 (es) 2019-01-24 2021-08-23 Composición cosmética/dermatológica

Country Status (15)

Country Link
US (1) US20220088061A1 (es)
EP (3) EP3689327A1 (es)
JP (1) JP2022523046A (es)
KR (1) KR20210126026A (es)
CN (1) CN113473963A (es)
AU (1) AU2019424624A1 (es)
BR (1) BR112021014505A2 (es)
CA (1) CA3127577A1 (es)
CO (1) CO2021011057A2 (es)
EA (1) EA202191780A1 (es)
IL (1) IL284995A (es)
MX (1) MX2021008812A (es)
SG (1) SG11202108124QA (es)
WO (1) WO2020151900A1 (es)
ZA (1) ZA202105405B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3120521B1 (fr) * 2021-03-15 2024-03-29 Hemarina Gel à base d’hémoglobine d’Annélides

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2781485B1 (fr) 1998-07-21 2003-08-08 Denis Barritault Polymeres biocompatibles leur procede de preparation et les compositions les contenant
FR2832708B1 (fr) * 2001-11-29 2004-02-13 Organes Tissus Regeneration Re Procede de sulfonation de composes comprenant des groupements hydroxyle (oh) libres ou des amines primaires ou secondaires
WO2005041986A2 (fr) 2003-10-28 2005-05-12 Organes Tissus Regeneration Reparation Remplacement - Otr3 Utilisation de polymeres biocompatibles pour la preparation d'une composition ou d'un dispositif medical
FR2861308A1 (fr) * 2003-10-28 2005-04-29 Organes Tissus Regeneration Re Utilisation de polymeres biocompatibles pour la preparation d'une composition pharmaceutique, dermatologique ou cosmetique destinee a la prevention, au soulagement ou au traitement des genes, desagrements et douleurs
EP1884231A1 (en) * 2006-08-01 2008-02-06 Auriga International S.A. Cosmetic or pharmaceutical composition containing hyaluronic acid
EP2740485B1 (en) * 2012-12-07 2018-10-31 Brightpulse Holding LTD. Protein slurp-1 for use in the treatment of ocular diseases
ES2523458B1 (es) * 2013-05-23 2015-07-15 José Manuel GALEANO SALVADOR Composición farmacéutica o cosmética para la regeneración y cicatrización de la piel
EP3097922A1 (fr) * 2015-05-28 2016-11-30 Denis Barritault Composition pour le traitement des lesions tissulaires
JP2023517579A (ja) * 2020-03-09 2023-04-26 オルガンズ ティシューズ リジェネレーション リパレーション レムプレースメント － オーティーアール３ 呼吸器系の病変の治療のための組成物

Also Published As

Publication number Publication date
EA202191780A1 (ru) 2021-11-08
US20220088061A1 (en) 2022-03-24
MX2021008812A (es) 2021-11-12
EP3914225A1 (fr) 2021-12-01
WO2020151900A1 (fr) 2020-07-30
ZA202105405B (en) 2023-01-25
CA3127577A1 (fr) 2020-07-30
SG11202108124QA (en) 2021-08-30
EP3685822A1 (fr) 2020-07-29
AU2019424624A1 (en) 2021-09-09
JP2022523046A (ja) 2022-04-21
EP3689327A1 (fr) 2020-08-05
CN113473963A (zh) 2021-10-01
BR112021014505A2 (pt) 2021-09-28
KR20210126026A (ko) 2021-10-19
IL284995A (en) 2021-09-30

Similar Documents

Publication Publication Date Title
CL2020001312A1 (es) Composiciones de cannabidiol y usos de las mismas. (divisional solicitud 201803425).
CO2019007298A2 (es) Inhibidores de tgfβ1 isoforma-específicos contexto-permisivos y uso de los mismos
PE20200617A1 (es) Anticuerpos anti-cd39, composiciones que comprenden anticuerpos anti-cd39, y metodos de uso de anticuerpos anti-cd39
CO2020010303A2 (es) Conjugados de il-15, y sus usos
CL2017002027A1 (es) Arni variante.
BR112015022148A2 (pt) combinações de substâncias ativas; preparações cosméticas ou dermatológicas; uso cosmético não terapêutico de preparações ou de combinações de substâncias ativas; e combinações de substâncias ativas e preparações
NI200800169A (es) Uso de derivados de sulfamidas heterocíclicas benzo-fusionadas para el tratamiento del dolor
BR112019024566A2 (pt) inibidores de pirazol magl
CO2020006907A2 (es) Péptidos antimicrobianos y métodos para usarlos
CO2017003290A2 (es) Composiciones y kits para desbridación enzimática y metodos de uso de los mismos
CL2019002574A1 (es) Moduladores de la expresión de pcsk9.
BR112015026388A8 (pt) uso de um composto de epoxi-tigliane, composto e composição farmacêutica
CL2021000924A1 (es) Uso de reboxetina para el tratamiento de narcolepsia
CL2021000224A1 (es) Formulaciones y composiciones farmacéuticas que comprenden una proteína de unión a antígeno enmascarada
BR112018073862A2 (pt) composição para cuidado dos cabelos
CO2021011057A2 (es) Composición cosmética/dermatológica
CL2020000056A1 (es) Nuevos derivados de xantina sustituidos.
CL2019002480A1 (es) Derivados de pirazol como inhibidores de bromodominio.
CL2020002519A1 (es) Composiciones de erenumab y usos de las mismas
CO2020008769A2 (es) Moduladores de la expresión dnm2
CL2018002577A1 (es) Forma física de un modulador sgr
CY1124986T1 (el) Υγρο σκευασμα που περιλαμβανει παεονολη και αποκυνινη
ECSP22021881A (es) Composición farmacéutica acuosa de anticuerpo anti-pd1 prolgolimab y su uso
BR112019001082A2 (pt) gel intestinal de levodopa e carbidopa e métodos de uso
DOP2020000104A (es) Métodos de uso y composiciones que contienen dulaglutida